Kevin Ali | Source | CEO at Organon

Kevin Ali is the CEO and board member of Organon, a global healthcare company with the
vision of creating a better and healthier every day for every woman around the world. Kevin led
the formation of Organon in 2021 to address the significant health issues that women face and
deliver impactful solutions all over the world.
Kevin has more than three decades of healthcare and commercial experience from Merck,
where he has held a number of leadership roles. Before leading Organon, Kevin was president
of Merck’s international business, responsible for all commercial markets outside the US which
account for 96% of the world's population and over half of Merck’s pharmaceutical revenues.
Under Kevin’s leadership, the international business was a significant driver of Merck’s growth.
Previously, Kevin served as the president of the emerging markets region where he transformed
the performance of many countries for sustained growth and strength. Earlier in his career, Kevin
was the managing director of Germany and Turkey and also led key therapeutic franchises for
the company.
Kevin holds an MBA from Santa Clara University and a Bachelor of Arts from the University of
California, Berkeley